Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
30 minutes of moderate exercise on an arm ergometer, a cycle ergometer, or a treadmill prior
to each administration of standard of care checkpoint blockade immunotherapy across all
cycles
Phase:
Early Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute